INIS
patients
100%
exercise
96%
control
85%
sex dependence
64%
circadian variations
64%
erythropoietin
64%
levels
64%
fats
64%
energy consumption
64%
genes
64%
mountains
64%
mexico
64%
nose
64%
quality of life
64%
tolerance
64%
asthma
64%
lungs
64%
regulations
64%
distance
59%
altitude
48%
women
48%
men
48%
therapy
42%
values
41%
concentration
32%
investigations
32%
oxygen
32%
hemoglobin
32%
competition
32%
affinity
32%
storage
32%
chains
32%
people
32%
cholesterol
32%
energy
32%
genetics
32%
proteins
32%
nutrition
32%
enrichment
32%
fatigue
27%
colombia
25%
defense
21%
gain
18%
variations
16%
blood
16%
acclimation
16%
hypothesis
16%
hormones
16%
dermatitis
14%
diseases
9%
symptoms
9%
hospitals
9%
gold
9%
cities
9%
environment
9%
cats
9%
hypertension
9%
adults
7%
comparative evaluations
7%
data
7%
doses
7%
evaluation
7%
us epa
7%
receptors
7%
corticosteroids
7%
eczema
7%
Keyphrases
Tarahumara
64%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
64%
Lung Response
64%
Respiratory Regulation
64%
Regulatory Component
64%
Molecular Properties
64%
Erythropoietin Levels
42%
Biological Agents
25%
Nasal Polyps
25%
Gene Set Enrichment Analysis
21%
Extreme Endurance
21%
Subcutaneous Fat
21%
Sandal
21%
Oxygen Affinity
21%
Genetic Investigation
21%
Endurance Athletes
21%
Vegetarian Diet
21%
Standardized Exercise Test
21%
Physical Resistance
21%
Mountain Trails
21%
Non-coding
21%
Elastic Energy
21%
Test Investigation
21%
Forefoot
21%
Beta Chain
21%
Plant Protein
21%
VO2max
21%
Physical Training
21%
Exercise Genetics
21%
Dyspnea Perception
12%
Exercise Endurance
12%
Elderly Health
12%
Observational Before-after Studies
12%
FEV1% Predicted
12%
Correspondence Should Be Addressed
8%
Desarrollo Sustentable
8%
US EPA
8%
Asthma Research
8%
Frequency Index
8%
ORCID
8%
Asthma Outcomes
6%
Exacerbation Rate
6%
Therapy Control
6%
Eczema
6%
Anti-IL-5
6%
Asthma Exacerbation
6%
Anti-IL-4
6%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
64%
Exercise Tolerance
64%
Quality of Life
64%
Comorbidity
64%
Severe Asthma
64%
Nasal Polyp
64%
Pulmonary Rehabilitation
64%
Dyspnea
38%
Rehabilitation Engineering
38%
Chronic Rhinosinusitis
35%
Biological Therapy
35%
Biological Product
28%
Asthma
21%
Allergic Rhinitis
14%
Atopic Dermatitis
14%
Endurance Training
12%
Charlson Comorbidity Index
12%
Silo-Filler's Disease
12%
Hypertension
12%
Elderly Patient
12%
St. George Respiratory Questionnaire
12%
Polypharmacy
12%
Interleukin 5
7%
Interleukin 4
7%
Therapy Effect
7%
Cohort Analysis
7%
Receptor
7%
Asthma Exacerbation
7%
Eczema
7%
Immunoglobulin E
7%